Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification?

Kittles RA, Chen W, Panguluri RK, Ahaghotu C, Jackson A, Adebamowo CA, Griffin R, Williams T, Ukoli F, Adams-Campbell L, Kwagyan J, Isaacs W, Freeman V, Dunston GM.

Hum Genet. 2002 Jun;110(6):553-60. Epub 2002 May 7.

PMID:
12107441
2.

Genetic contribution to variable human CYP3A-mediated metabolism.

Lamba JK, Lin YS, Schuetz EG, Thummel KE.

Adv Drug Deliv Rev. 2002 Nov 18;54(10):1271-94. Review.

PMID:
12406645
3.

CYP3A4 polymorphisms--potential risk factors for breast and prostate cancer: a HuGE review.

Keshava C, McCanlies EC, Weston A.

Am J Epidemiol. 2004 Nov 1;160(9):825-41. Review.

4.

Hereditary prostate cancer and other genetic predispositions to prostate cancer.

Cussenot O, Valeri A, Berthon P, Fournier G, Mangin P.

Urol Int. 1998;60 Suppl 2:30-4; discussion 35. Review.

PMID:
9607556
5.

Genetic predisposition to prostate cancer: possible explanations for ethnic differences in risk.

Shibata A, Whittemore AS.

Prostate. 1997 Jun 15;32(1):65-72. Review.

PMID:
9207959
6.

Detecting association in a case-control study while correcting for population stratification.

Reich DE, Goldstein DB.

Genet Epidemiol. 2001 Jan;20(1):4-16. Review.

PMID:
11119293
7.

Ethnic and racial differences in prostate cancer incidence and mortality.

Farkas A, Marcella S, Rhoads GG.

Ethn Dis. 2000 Winter;10(1):69-75. Review.

PMID:
10764132
8.

Linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in the African-American population.

Gilbert SM, Benson MC, McKiernan JM.

Curr Urol Rep. 2002 Jun;3(3):189-93. Review.

PMID:
12084187
9.

Hereditary prostate cancer in African-American families.

Cooney KA.

Semin Urol Oncol. 1998 Nov;16(4):202-6. Review.

PMID:
9858326
10.

Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.

Farrell J, Petrovics G, McLeod DG, Srivastava S.

Int J Mol Sci. 2013 Jul 25;14(8):15510-31. doi: 10.3390/ijms140815510. Review.

11.

Incidence and etiology of prostate cancer.

Hutchison GB.

Urology. 1981 Mar;17(Suppl 3):4-10. Review. No abstract available.

PMID:
7010754
12.

Review: prostate cancer epidemiology.

Flanders WD.

Prostate. 1984;5(6):621-9. Review.

PMID:
6387660
13.

Review of studies on metabolic genes and cancer in populations of African descent.

Ragin CC, Langevin S, Rubin S, Taioli E.

Genet Med. 2010 Jan;12(1):12-8. doi: 10.1097/GIM.0b013e3181c8e160. Review.

14.

Prostate cancer and African-American men.

Powell IJ.

Oncology (Williston Park). 1997 May;11(5):599-605; discussion 606-15 passim. Review.

15.

Biological determinants of health disparities in prostate cancer.

Martin DN, Starks AM, Ambs S.

Curr Opin Oncol. 2013 May;25(3):235-41. doi: 10.1097/CCO.0b013e32835eb5d1. Review.

PMID:
23399519
16.

Reassessing 'hereditary' interethnic differences in anemia status.

Jackson RT, Jackson FL.

Ethn Dis. 1991 Winter;1(1):26-41. Review.

PMID:
1842518
17.

Hereditary intermediate phenotypes in African American hypertension.

Kailasam MT, O'Connor DT, Parmer RJ.

Ethn Health. 1996 May;1(2):117-28. Review.

PMID:
9395555
18.

Using ancestry-informative markers to define populations and detect population stratification.

Enoch MA, Shen PH, Xu K, Hodgkinson C, Goldman D.

J Psychopharmacol. 2006 Jul;20(4 Suppl):19-26. Review.

PMID:
16785266
19.

Cytochrome P450 pharmacogenetics in African populations.

Alessandrini M, Asfaha S, Dodgen TM, Warnich L, Pepper MS.

Drug Metab Rev. 2013 May;45(2):253-75. doi: 10.3109/03602532.2013.783062. Epub 2013 Apr 16. Review.

PMID:
23590174
20.
Items per page

Supplemental Content

Write to the Help Desk